Pricing Log in Create free account

Citius Pharmaceuticals, Inc. (CTXR) vs Neuphoria Therapeutics Inc. (NEUP)

Citius Pharmaceuticals, Inc. and Neuphoria Therapeutics Inc. are both Biotechnology companies. Citius Pharmaceuticals, Inc. and Neuphoria Therapeutics Inc. are of similar size ($15.3M and $15.0M). Across the 10 metrics below, Citius Pharmaceuticals, Inc. leads on 5 and Neuphoria Therapeutics Inc. on 5.

Valuation

Metric CTXR NEUP Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.79 9.40
P/B 0.19 0.50 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.39 0.66
EV/Sales n/m (0.42) 9.02
Earnings yield (387.87%) (180.00%) (32.88%)
Free cash flow yield (242.31%) (99.13%) (23.13%)

Profitability

Metric CTXR NEUP Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (64.51%) (61.70%) (51.96%)
Return on assets (34.29%) (46.95%) (46.06%)
Return on invested capital (58.74%) (232.67%) 0.00%

Growth

Metric CTXR NEUP Biotechnology median
Revenue growth (TTM) — 3,535.05% 6.76%
EPS growth (last fiscal year) 43.38% (1,230.43%) 29.88%
Revenue growth, 5-year CAGR — 19.07% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CTXR NEUP Biotechnology median
Debt to equity 0.08 0.00 0.00
Current ratio 0.84 27.85 4.97
Net debt to EBITDA 0.11 1.26 1.01

Dividend

Metric CTXR NEUP Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CTXR NEUP Biotechnology median
Market cap 15.31m 14.99m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack